Literature DB >> 17999208

A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant.

Zoltan Szolnoki1, Andras Kondacs, Yvette Mandi, Ferenc Somogyvari.   

Abstract

Although the main pathomechanism of multiple sclerosis (MS) is not known, an autoimmune response is presumed to involve its evolution and propagation. In this study, we examined how the kinesin light-chain 1 (KLC1) G56836C (rs8702) single nucleotide polymorphism (SNP) in intron 13 affects the occurrence of MS. This genetic variant was found to be associated with cognitive disturbances and neurodegeneration, and it was presumed to affect the kinesin function. Kinesin serves as a main cytoskeleton motor protein by carrying mitochondria and the molecular apparatus of myelin basic protein synthesis. The present association analysis of this genetic variant was performed in 102 relapsing-remitting MS patients and in 207 neuroimaging alteration-free controls. The KLC1 56836CC variant proved to exert a significant protective effect on the occurrence of MS (2.0% vs. 9.7%, P < 0.02; crude OR: 0.19, 95% CI: 0.04-0.82, P < 0.05; adjusted OR: 0.21, 95% CI: 0.018-0.88, P < 0.05). Our results draw attention to possible roles of the cytoskeleton in MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999208     DOI: 10.1007/s12017-007-8014-x

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  26 in total

Review 1.  Mitochondria in cell death: novel targets for neuroprotection and cardioprotection.

Authors:  Mark P Mattson; Guido Kroemer
Journal:  Trends Mol Med       Date:  2003-05       Impact factor: 11.951

2.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.

Authors:  S Komoly; L D Hudson; H D Webster; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

5.  A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Ferenc Somogyvari
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.

Authors:  Malin E Andersson; Annica Sjölander; Niels Andreasen; Lennart Minthon; Oskar Hansson; Nenad Bogdanovic; Christina Jern; Katarina Jood; Anders Wallin; Kaj Blennow; Henrik Zetterberg
Journal:  Int J Mol Med       Date:  2007-08       Impact factor: 4.101

Review 7.  Ischemic delayed neuronal death. A mitochondrial hypothesis.

Authors:  K Abe; M Aoki; J Kawagoe; T Yoshida; A Hattori; K Kogure; Y Itoyama
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

8.  Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles.

Authors:  B Trinczek; A Ebneth; E M Mandelkow; E Mandelkow
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

9.  Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.

Authors:  Malin E Andersson; Madeleine Zetterberg; Gunnar Tasa; Mona Seibt-Palmér; Erkki Juronen; Pait Teesalu; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  4 in total

1.  Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV.

Authors:  Ghantasala S Sameer Kumar; Abhilash K Venugopal; Manoj Kumar Kashyap; Rajesh Raju; Arivusudar Marimuthu; Shyam Mohan Palapetta; Yashwanth Subbanayya; Renu Goel; Ankit Chawla; Jyoti Bajpai Dikshit; Pramila Tata; H C Harsha; Jagadeesha Maharudraiah; Y L Ramachandra; Parthasarathy Satishchandra; T S Keshava Prasad; Akhilesh Pandey; Anita Mahadevan; S K Shankar
Journal:  J Proteomics Bioinform       Date:  2012-09-09

Review 2.  Alternative splicing in multiple sclerosis and other autoimmune diseases.

Authors:  Irina Evsyukova; Jason A Somarelli; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  A homozygous genetic variant of mitochondrial uncoupling protein 4 exerts protection against the occurrence of multiple sclerosis.

Authors:  Zoltan Szolnoki; Andras Kondacs; Yvette Mandi; Anita Bodor; Ferenc Somogyvari
Journal:  Neuromolecular Med       Date:  2009-06-18       Impact factor: 3.843

4.  Kinesin light chain 1 gene haplotypes in three conformational diseases.

Authors:  Malin von Otter; Sara Landgren; Staffan Nilsson; Caroline Lundvall; Lennart Minthon; Nenad Bogdanovic; Niels Andreasen; Deborah R Gustafson; Ingmar Skoog; Anders Wallin; Anna Håkansson; Hans Nissbrandt; Madeleine Zetterberg; Gunnar Tasa; Kaj Blennow; Henrik Zetterberg
Journal:  Neuromolecular Med       Date:  2009-11-13       Impact factor: 3.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.